Please note that Precision Radiation Oncology is a fully open-access journal. All articles accepted for publication will be published open access under a creative commons license, making them immediately freely available to read, download and share. For more information on the Wiley Open Access publishing program, visit the Wiley Open Access page.
1. MANUSCRIPT SUBMISSION
Thank you for your interest in Precision Radiation Oncology. Please read the complete Author Guidelines carefully prior to submission. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://wiley.atyponrex.com/journal/PRO6. We are looking forward to your submission.
The submission system will encourage authors to use an ORCID iD (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.
2. EDITORIAL CONSIDERATIONS
Aims and Scope
Precision Radiation Oncology aims to offer a forum for collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and clinical research in radiation oncology. The editors encourage contributions relevant to radio diagnosis, radiotherapy, radiation physics, radiation biology, interventional therapy, and nuclear medicine in cancer, including basic cancer research, as well as translational and clinical cancer research.
The editors welcome submissions in the form of Original Articles, Clinical Guidelines, Consensus, Commentaries, Editorials, Reviews, Meeting Reports, Case Reports, Brief Reports, Research Letters, Letters to the Editor, and Perspective.
Precision Radiation Oncology is supported by the Sino-American Network for Therapeutic Radiology and Oncology and the Chinese Anti-Cancer Association.
